IO Biotech, Inc. most recently reported annual revenue of $0, a net loss of $95.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
IO Biotech, Inc.: net profit was positive in 0 of 6 reported years; the most recent year shows a net loss of $95.0M.
Income Statement — 6 Years (USD millions)
Metric
2019
2020
2021
2022
2023
2024
Revenue
$0
$0
$0
$0
$0
$0
Operating Expenses
$10.0M
$10.0M
$41.0M
$71.0M
$91.0M
$95.0M
Operating Profit
$-10.0M
$-10.0M
$-41.0M
$-71.0M
$-91.0M
$-95.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Other Income
$-1.0M
$-2.0M
$-27.0M
$1.0M
$6.0M
$1.0M
Interest
$0
$0
$0
$0
$0
$0
Depreciation
$10.0M
$0
$0
$1.0M
$1.0M
$1.0M
Profit Before Tax
$-11.0M
$-12.0M
$-68.0M
$-70.0M
$-85.0M
$-94.0M
Tax
$0
$0
$-100,000
$-1.8M
$-1.0M
$-1.5M
Net Profit
$-11.0M
$-12.0M
$-68.0M
$-71.0M
$-86.0M
$-95.0M
EPS
$-60.66
$-1.05
$-2.36
$-2.48
$-1.98
$-1.45
Dividend Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Operating Expenses
$20.0M
$18.0M
$22.0M
$23.0M
$28.0M
$20.0M
$22.0M
$27.0M
$27.0M
$23.0M
$23.0M
$19.0M
Operating Profit
$-20.0M
$-18.0M
$-22.0M
$-23.0M
$-28.0M
$-20.0M
$-22.0M
$-27.0M
$-27.0M
$-23.0M
$-23.0M
$-19.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Interest
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$1.0M
Profit Before Tax
$-19.0M
$-17.0M
$-21.0M
$-22.0M
$-26.0M
$-19.0M
$-20.0M
$-24.0M
$-31.0M
$-22.0M
$-26.0M
$-10.0M
Tax
$-5.2M
$-2.4M
$-2.6M
$2.0M
$-1.4M
$-2.2M
$-1.8M
$-880,000
$-1.4M
$-660,000
$-450,000
$16.6M
Net Profit
$-20.0M
$-17.0M
$-21.0M
$-22.0M
$-26.0M
$-19.0M
$-21.0M
$-24.0M
$-31.0M
$-22.0M
$-26.0M
$-8.0M
EPS
$-0.70
$-0.59
$-0.73
$-0.43
$-0.40
$-0.30
$-0.31
$-0.36
$-0.48
$-0.34
$-0.40
$-0.13
Over the 6 years reported for IO Biotech, Inc., borrowings decreased from $9.0M in 2019 to $2.0M in 2024, cash stood at $60.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.42 times.
Balance Sheet — 6 Years (USD millions)
Metric
2019
2020
2021
2022
2023
2024
Total Assets
$9.0M
$6.0M
$222.0M
$152.0M
$151.0M
$68.0M
Current Assets
$9.0M
$6.0M
$222.0M
$148.0M
$147.0M
$65.0M
Cash
$8.0M
$3.0M
$212.0M
$143.0M
$143.0M
$60.0M
Inventory
$0
$0
$0
$0
$0
$0
Receivables
$1.0M
$2.0M
$2.0M
$2.0M
$1.0M
$1.0M
Fixed Assets
$0
$0
$0
$3.0M
$3.0M
$2.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
Investments
$0
$0
$0
$0
$0
$0
Other Assets
$0
$0
$0
$0
$0
$0
Total Liabilities
$11.0M
$3.0M
$10.0M
$13.0M
$18.0M
$21.0M
Current Liabilities
$11.0M
$3.0M
$10.0M
$11.0M
$16.0M
$19.0M
Borrowings
$9.0M
$0
$0
$3.0M
$2.0M
$2.0M
Other Liabilities
$2.0M
$3.0M
$10.0M
$10.0M
$15.0M
$19.0M
Equity
$0
$0
$0
$0
$0
$0
Reserves
$-1.0M
$3.0M
$212.0M
$139.0M
$133.0M
$47.0M
For IO Biotech, Inc., operating cash flow was positive in 0 of 6 reported years; free cash flow in the latest year was negative at $82.0M; free cash flow was positive in 0 of 6 years.
Cash Flow Statement — 6 Years (USD millions)
Metric
2019
2020
2021
2022
2023
2024
Operating Cash Flow
$-9.0M
$-10.0M
$-41.0M
$-60.0M
$-72.0M
$-82.0M
Investing Cash Flow
$0
$0
$0
$-1.0M
$-1.0M
$0
Financing Cash Flow
$0
$0
$-12.0M
$0
$-3.0M
$0
Net Cash Flow
$0
$-4.0M
$208.0M
$-69.0M
$1.0M
$-83.0M
Free Cash Flow
$-9.0M
$-10.0M
$-41.0M
$-60.0M
$-72.0M
$-82.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.01
EV / EBITDA
0.50
FCF Yield
-6935.72%
Quick Ratio
2.01
Interest Coverage
-57.16
Return 1Y
—
Return 3Y
—
Return 5Y
—
IO Biotech, Inc. (IOBT) financials — frequently asked questions
What is IO Biotech, Inc.'s annual revenue?
IO Biotech, Inc. (IOBT) reported annual revenue of $0 in its most recent fiscal year.
What is IO Biotech, Inc.'s net profit?
IO Biotech, Inc. (IOBT) reported a net loss of $95.0M in its most recent fiscal year.
What is IOBT EV/EBITDA?
IO Biotech, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 0.50.